These processes could be reversed by either PDE5A inhibitors or PKG1 overexpression. 4.1. siRNA inhibited both NOS3 phosphorylation (S1179) and activity, indicating a book function
Structure-Based Design of mTORC1 Inhibitors in Cancer Therapy
mTORC1 inhibitor